NO20074087L - Oralt disintegrert sammensetning av olanzapin eller donepezil - Google Patents
Oralt disintegrert sammensetning av olanzapin eller donepezilInfo
- Publication number
- NO20074087L NO20074087L NO20074087A NO20074087A NO20074087L NO 20074087 L NO20074087 L NO 20074087L NO 20074087 A NO20074087 A NO 20074087A NO 20074087 A NO20074087 A NO 20074087A NO 20074087 L NO20074087 L NO 20074087L
- Authority
- NO
- Norway
- Prior art keywords
- olanzapine
- donepezil
- orally disintegrated
- disintegrated composition
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000664A EP1681048A1 (en) | 2005-01-14 | 2005-01-14 | Orally disintegrating composition of olanzapine or donepezil |
| PCT/EP2006/000284 WO2006074951A2 (en) | 2005-01-14 | 2006-01-13 | Orally disintegrating composition of olanzapine or donepezil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074087L true NO20074087L (no) | 2007-10-09 |
Family
ID=34933289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074087A NO20074087L (no) | 2005-01-14 | 2007-08-07 | Oralt disintegrert sammensetning av olanzapin eller donepezil |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1681048A1 (sl) |
| AT (1) | ATE465719T1 (sl) |
| AU (1) | AU2006205817A1 (sl) |
| DE (1) | DE602006013940D1 (sl) |
| DK (1) | DK1845954T3 (sl) |
| EA (1) | EA013742B1 (sl) |
| ES (1) | ES2344959T3 (sl) |
| HR (1) | HRP20100399T1 (sl) |
| NO (1) | NO20074087L (sl) |
| PL (1) | PL1845954T3 (sl) |
| PT (1) | PT1845954E (sl) |
| SI (1) | SI1845954T1 (sl) |
| UA (1) | UA89394C2 (sl) |
| WO (1) | WO2006074951A2 (sl) |
| ZA (1) | ZA200706692B (sl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879382B2 (en) | 2005-09-30 | 2011-02-01 | Fmc Corporation | Stabilizers and compositions and products comprising same |
| DE102005060377A1 (de) * | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
| JP5535616B2 (ja) * | 2006-03-31 | 2014-07-02 | ルビコン リサーチ プライベート リミテッド | 口腔内崩壊錠剤のための直接圧縮性複合材 |
| GB0614586D0 (en) * | 2006-07-22 | 2006-08-30 | Pliva Istrazivacki Inst D O O | Pharmaceutical Formulation |
| DK2248519T3 (en) * | 2006-10-02 | 2018-01-02 | Applied Pharma Res | Non-mucoadhesive film dosage forms |
| WO2008057267A2 (en) * | 2006-10-27 | 2008-05-15 | Fmc Corporation | Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations |
| EP2133096A4 (en) | 2007-03-13 | 2011-11-16 | Dainippon Sumitomo Pharma Co | IN THE MOUTHING TABLET |
| BRPI0817927A2 (pt) | 2007-10-01 | 2015-04-07 | Lesvi Laboratorios Sl | Comprimidos orodispersiveis |
| CN101756917A (zh) * | 2008-10-24 | 2010-06-30 | 北京科信必成医药科技发展有限公司 | 盐酸多奈哌齐口腔崩解片及其制备方法 |
| EP2391350A1 (en) * | 2008-12-18 | 2011-12-07 | Ranbaxy Laboratories Limited | Atazanavir formulations |
| EP2198857A1 (en) | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Oral dispersible tablet |
| TR200903293A1 (tr) | 2009-04-28 | 2010-11-22 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan olanzapin tablet. |
| TR201002084A1 (tr) * | 2010-03-19 | 2011-10-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi |
| FR2962331B1 (fr) * | 2010-07-06 | 2020-04-24 | Ethypharm | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
| WO2012014012A1 (es) * | 2010-07-27 | 2012-02-02 | Laboratorios Andrómaco S.A. | Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia. |
| PL2764045T3 (pl) | 2011-10-05 | 2017-08-31 | Fmc Corporation | Kompozycja stabilizatora ze współścieranej celulozy mikrokrystalicznej i karboksymetylocelulozy, sposób wytwarzania i zastosowania |
| BR112014007366B1 (pt) | 2011-10-05 | 2020-09-15 | Dupont Nutrition Usa, Inc | Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma |
| ES2628612T3 (es) | 2011-12-09 | 2017-08-03 | Fmc Corporation | Composición estabilizadora coerosionada |
| WO2014027975A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Novel orally administered pharmaceutical formulations |
| FR2999432B1 (fr) * | 2012-12-17 | 2014-12-12 | Ethypharm Sa | Comprimes orodispersibles obtenus par compression moulage |
| CN104510717B (zh) * | 2013-09-27 | 2019-02-05 | 江苏豪森药业集团有限公司 | 奥氮平口崩片及其制备方法 |
| CN108261399A (zh) * | 2016-12-30 | 2018-07-10 | 江苏豪森药业集团有限公司 | 奥氮平口腔崩解片及其制备方法 |
| CN108926543A (zh) * | 2017-05-26 | 2018-12-04 | 万全万特制药江苏有限公司 | 一种奥氮平口腔崩解片及其制备方法 |
| CN109498544A (zh) * | 2017-09-15 | 2019-03-22 | 万全万特制药江苏有限公司 | 稳定的奥氮平组合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1260215B1 (en) * | 2000-03-01 | 2009-07-29 | Eisai R&D Management Co., Ltd. | Rapidly disintegrable tablet containing polyvinyl alcohol |
| AU2002255196A1 (en) * | 2002-04-18 | 2003-10-27 | Dr. Reddy's Laboratories Ltd. | Rapidly dispersing solid oral compositions |
-
2005
- 2005-01-14 EP EP05000664A patent/EP1681048A1/en not_active Withdrawn
-
2006
- 2006-01-13 DK DK06701464.7T patent/DK1845954T3/da active
- 2006-01-13 AT AT06701464T patent/ATE465719T1/de active
- 2006-01-13 PT PT06701464T patent/PT1845954E/pt unknown
- 2006-01-13 WO PCT/EP2006/000284 patent/WO2006074951A2/en active Application Filing
- 2006-01-13 EP EP06701464A patent/EP1845954B1/en active Active
- 2006-01-13 AU AU2006205817A patent/AU2006205817A1/en not_active Abandoned
- 2006-01-13 UA UAA200709252A patent/UA89394C2/uk unknown
- 2006-01-13 EA EA200701462A patent/EA013742B1/ru not_active IP Right Cessation
- 2006-01-13 PL PL06701464T patent/PL1845954T3/pl unknown
- 2006-01-13 ES ES06701464T patent/ES2344959T3/es active Active
- 2006-01-13 DE DE602006013940T patent/DE602006013940D1/de active Active
- 2006-01-13 SI SI200630726T patent/SI1845954T1/sl unknown
-
2007
- 2007-08-07 NO NO20074087A patent/NO20074087L/no not_active Application Discontinuation
- 2007-08-13 ZA ZA200706692A patent/ZA200706692B/en unknown
-
2010
- 2010-07-20 HR HR20100399T patent/HRP20100399T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1681048A1 (en) | 2006-07-19 |
| EA200701462A1 (ru) | 2008-02-28 |
| HRP20100399T1 (hr) | 2010-09-30 |
| ES2344959T3 (es) | 2010-09-10 |
| EP1845954B1 (en) | 2010-04-28 |
| DK1845954T3 (da) | 2010-08-16 |
| WO2006074951A2 (en) | 2006-07-20 |
| SI1845954T1 (sl) | 2010-08-31 |
| WO2006074951A3 (en) | 2007-04-26 |
| ZA200706692B (en) | 2008-07-30 |
| PL1845954T3 (pl) | 2010-10-29 |
| DE602006013940D1 (de) | 2010-06-10 |
| PT1845954E (pt) | 2010-08-02 |
| EP1845954A2 (en) | 2007-10-24 |
| UA89394C2 (uk) | 2010-01-25 |
| EA013742B1 (ru) | 2010-06-30 |
| ATE465719T1 (de) | 2010-05-15 |
| AU2006205817A1 (en) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074087L (no) | Oralt disintegrert sammensetning av olanzapin eller donepezil | |
| TW200621313A (en) | Pharmaceutical compositions | |
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| NI201100143A (es) | Composición farmacéutica sólida que comprende amlodipina y losartan. | |
| NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
| WO2007098270A3 (en) | Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same | |
| BRPI0711889B8 (pt) | método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina | |
| CL2007003821A1 (es) | Compuestos derivados de isoquinolina o isoquinolinona sustituidos con cicloalquilamina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades asociadas con la rho-quinasa y/o la fosforilacion mediada por la rho-quinasa de la cadena ligera de miosina, tales como hipertension, retinopatia, glaucoma, alzheimer, sida entre otras. | |
| HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
| CR10497A (es) | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38 | |
| EA200601608A1 (ru) | Способ производства твёрдой фармацевтической композиции | |
| NO20076371L (no) | Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner | |
| DE602006006536D1 (de) | Trockene Aripiprazolformulierungen | |
| MX2007011847A (es) | Derivados de pirimidindiona como antagonistas del receptor de procineticina 2. | |
| HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| ATE519373T1 (de) | Teezusammensetzung und herstellungsverfahren dafür | |
| EA201401193A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
| EA200701817A1 (ru) | Новые соли 6-гетероциклических замещенных производных гексагидрофенантридина | |
| NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
| NI200900207A (es) | Una composición de liberación prolongada que comprende un derivado de somatostatina en micropartículas. | |
| WO2006075139A3 (en) | Novel process for the preparation of substituted indoles | |
| WO2008137134A3 (en) | Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide | |
| NO20073046L (no) | Utvalgte benzofuranderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |